Fundz

Xylocor Therapeutics, Inc. reported raising $60,000 in an initial SEC Form D filing, from an offering of $150,000

PRIVATEMar 19, 2018$60K of $150K raised

Amount Raised

$60,000

$60,000 sold, per SEC Form D (first sale Mar 19, 2018)

Round Type

Pre-Seed

MalvernBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as XyloCor Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • NutriBand Inc. raised $1M (Seed) on May 3, 2018.
  • GenoPalate raised $357K (Seed) on May 3, 2018.
  • valisure llc raised $300K (Seed) on May 3, 2018.
  • ProMIS Neurosciences raised $1.7M on May 3, 2018.
  • Mellitus, LLC raised $5.6M on May 3, 2018.
  • Dermala Inc. raised $1M (Seed) on May 2, 2018.

Who to call at XyloCor Therapeutics, Inc., and when

A new round usually means XyloCor Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day XyloCor Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at XyloCor Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at XyloCor Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

XyloCor Therapeutics, Inc.

Location

39 Addison Lane

Malvern, Pennsylvania, United States

About

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment XyloCor Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsEric D., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for XyloCor Therapeutics, Inc.'s next move

See what Strategic adds

XyloCor Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.